Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
about
TRAF3 deficiency promotes metabolic reprogramming in B cellsImmune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis.Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.Vinexin β Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor κB Inflammatory Axis.Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice.MicroRNA-191, acting via the IRS-1/Akt signaling pathway, is involved in the hepatic insulin resistance induced by cigarette smoke extract.The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.Adipocyte-Macrophage Cross-Talk in Obesity.Insights into innate immune signalling in controlling cardiac remodelling.TRAF molecules in inflammation and inflammatory diseases.Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesisThe role of K63-linked polyubiquitination in cardiac hypertrophy
P2860
Q28820861-DB83BA64-2950-4FFE-9429-12807529B846Q33881724-48D20E8B-3F73-4BA7-86EB-4597B17F4A0FQ37556276-BBF848C0-46F6-420A-8C12-912AF3F71A17Q38288136-E9822AD0-6D6F-45C3-9B69-368EE9991A8CQ38289759-30888A6E-2C95-4CC4-B1D4-AD65A6620436Q38956523-50BD540E-2939-4F96-BD89-019101B5A88FQ41102495-3DFA1D05-4852-4A3C-9B2F-89E0F3B4D22FQ43365390-A716FA9B-8C50-4DDE-A5AA-E96EF7A618BDQ47308542-82768C2F-BAE3-4460-83E5-6F5E01AD18C4Q48326227-58A4C0BE-D38D-4C2A-913E-049B428BF054Q48614912-C59C8FC7-DDC6-4CE4-8991-152D046F7DB1Q50884645-C2C4FCA6-B133-4334-9AC0-37E9F675B533Q50884722-87A1E698-E64B-4051-A440-ADF96469ED8AQ50957783-AFB51F71-E96D-430C-BFBE-C774C3979135Q52448624-012A5897-05DE-43C6-9783-A8CCE7CE5D75Q52661592-2EA942D4-7906-40B9-988C-286C8CF99DE0Q57460028-88B2DD16-C667-4041-A702-28644AF11E53Q58784086-5DF927DA-F0E3-4CEF-94F2-A0C58DAF3CA4
P2860
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@ast
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@en
type
label
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@ast
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@en
prefLabel
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@ast
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@en
P2093
P2860
P356
P1476
Hepatocyte TRAF3 promotes live ...... ting TAK1-dependent signalling
@en
P2093
Guang-Nian Zhao
Hongliang Li
Junhong Guo
Peng Zhang
Pengcheng Luo
Pi-Xiao Wang
Sijun Yang
Xiao-Jing Zhang
Xueyong Zhu
P2860
P2888
P356
10.1038/NCOMMS10592
P407
P577
2016-02-17T00:00:00Z